Search results
Blueprint Medicines (NASDAQ:BPMC) pulls back 3.5% this week, but still delivers shareholders notable...
Simply Wall St. via Yahoo Finance· 10 hours agoIf you want to compound wealth in the stock market, you can do so by buying an index fund. But...
Blueprint Medicines Co. (NASDAQ:BPMC) Forecasted to Post Q2 2024 Earnings of ($1.40) Per Share
ETF DAILY NEWS· 6 days agoBlueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Analysts at Zacks Research issued their Q2 2024 earnings per share estimates for shares of
Blueprint Medicines Corp [BPMC] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 7 days agoBlueprint Medicines Corp’s recent filing unveils that its CHIEF FINANCIAL OFFICER Landsittel Michael unloaded Company’s shares for reported $1.05 million ...
Jim Harbaugh, Chargers back in action: 12 observations from first OTA practice
New York Times· 1 day agoThe Los Angeles Chargers held their opening organized team activity of the Jim Harbaugh era on...
Andrew Huberman Signs With WME (EXCLUSIVE)
Variety· 1 day agoNeuroscientist and Stanford School of Medicine tenured professor Andrew Huberman, Ph.D., has signed with WME. The agency will work with Huberman to...
Is Madrigal Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 12 hours agoConsider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $566,624!* Stock Advisor...
10 Health Care Stocks Whale Activity In Today's Session - Ardelyx (NASDAQ:ARDX), Blueprint Medicines...
Benzinga· 4 days agoLoading... Loading... This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga ...
Study provides blueprint for hybrid-virtual home visit model to support patients who do not live...
Medical Xpress· 6 days agoThe work is published in the Journal of General Internal Medicine. U.S. Department of Veteran...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 6 days agoMeanwhile, Dupixent, a medicine for eczema, is racing toward a major approval in treating COPD, one...
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Motley Fool via Yahoo Finance· 14 hours agoConsider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our...
